Drug Profile
Research programme: diabetes VPAC2 receptor agonists - Forbes Medi-Tech
Alternative Names: FM-TP2000 seriesLatest Information Update: 27 May 2008
Price :
$50
*
At a glance
- Originator Forbes Medi-Tech
- Class
- Mechanism of Action Vasoactive intestinal peptide type II receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 27 May 2008 Discontinued - Preclinical for Diabetes mellitus in USA (unspecified route)
- 04 Apr 2007 Preclinical trials in Diabetes mellitus in USA (unspecified route)